Featured Research

from universities, journals, and other organizations

Timing Is Everything When Using IL-7 To Boost Antiviral Immunity

Date:
February 3, 2008
Source:
Journal of Clinical Investigation
Summary:
CD8+ T cells are an important component of the antiviral immune response. Much research effort is being invested in identifying new ways to boost antiviral immune responses in individuals with chronic viral infections. Although the use of the soluble factor IL-7 has proven attractive, new data indicate that the timing of IL-7 treatment is important in determining how effective it is at enhancing antiviral immunity.

CD8+ T cells are an important component of antiviral immune responses.

Much research effort is being invested in identifying new ways to boost antiviral immune responses in individuals with chronic viral infections (such as those infected with HIV and hepatitis C virus) and to boost the efficacy of vaccines designed to target these viruses.

The use of the soluble factor IL-7, which is known to be important in the generation and maintenance of memory CD8+ T cells, has proven attractive. However, new data, generated in mice by M. Suresh and colleagues at the University of Wisconsin--Madison, have indicated that the timing of IL-7 treatment is important in determining how effective it is at enhancing antiviral immunity.

In the study, IL-7 was shown to enhance the number and function of memory CD8+ T cells only if it was administered during the contraction phase of the immune response mounted after mice were infected with either lymphocytic choriomeningitis virus or vaccinia virus, or were administered a DNA vaccine.

Importantly, CD8+ T cells from IL-7--treated mice exhibited improved viral control. These data have clinical implications for the use of IL-7 as an immunotherapeutic agent both to bolster vaccine-induced CD8+ T cell memory and to boost the immune response of individuals with a chronic viral infection.

The article "Effects of IL-7 on memory CD8+ T cell homeostasis are influenced by the timing of therapy in mice" was published in the Journal of Clinical Investigation February 1, 2008.


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "Timing Is Everything When Using IL-7 To Boost Antiviral Immunity." ScienceDaily. ScienceDaily, 3 February 2008. <www.sciencedaily.com/releases/2008/02/080203101434.htm>.
Journal of Clinical Investigation. (2008, February 3). Timing Is Everything When Using IL-7 To Boost Antiviral Immunity. ScienceDaily. Retrieved April 17, 2014 from www.sciencedaily.com/releases/2008/02/080203101434.htm
Journal of Clinical Investigation. "Timing Is Everything When Using IL-7 To Boost Antiviral Immunity." ScienceDaily. www.sciencedaily.com/releases/2008/02/080203101434.htm (accessed April 17, 2014).

Share This



More Health & Medicine News

Thursday, April 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Is Apathy A Sign Of A Shrinking Brain?

Is Apathy A Sign Of A Shrinking Brain?

Newsy (Apr. 17, 2014) A recent study links apathetic feelings to a smaller brain. Researchers say the results indicate a need for apathy screening for at-risk seniors. Video provided by Newsy
Powered by NewsLook.com
Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com
Thousands Of Vials Of SARS Virus Go Missing

Thousands Of Vials Of SARS Virus Go Missing

Newsy (Apr. 16, 2014) A research institute in Paris somehow misplaced more than 2,000 vials of the deadly SARS virus. Video provided by Newsy
Powered by NewsLook.com
Formerly Conjoined Twins Released From Dallas Hospital

Formerly Conjoined Twins Released From Dallas Hospital

Newsy (Apr. 16, 2014) Conjoined twins Emmett and Owen Ezell were separated by doctors in August. Now, nearly nine months later, they're being released from the hospital. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins